Intellectus Partners’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.91M	Buy	546,083 +22,700	+4%	+$81.7K	0.39%	69
2025 Q4	$1.79M	Sell	523,383 -19,750	-4%	-$88.2K	0.35%	75
2025 Q3	$2.73M	Sell	543,133 -5,000	-0.9%	-$22K	0.53%	48
2025 Q2	$1.88M	Hold	548,133	–	–	0.41%	66
2025 Q1	$1.22M	Buy	548,133 +600	+0.1%	+$1.72K	0.3%	96
2024 Q4	$1.6M	Buy	547,533 +2,000	+0.4%	+$5.57K	0.36%	77
2024 Q3	$1.42M	Hold	545,533	–	–	0.36%	84
2024 Q2	$1.61M	Buy	545,533 +3,750	+0.7%	+$14.2K	0.44%	62
2024 Q1	$2.45M	Sell	541,783 -345,500	-39%	-$1.76M	0.65%	40
2023 Q4	$5.07M	Buy	887,283 +10,650	+1%	+$49.4K	1.46%	10
2023 Q3	$4.03M	Sell	876,633 -800	-0.1%	-$4.87K	1.28%	10
2023 Q2	$5.67M	Buy	877,433 +4,950	+0.6%	+$33.8K	1.7%	8
2023 Q1	$6.58M	Buy	872,483 +3,900	+0.4%	+$35.4K	2.08%	6
2022 Q4	$8.8M	Sell	868,583 -222,922	-20%	-$2.58M	3.06%	1
2022 Q3	$10.8M	Buy	1,091,505 +1,750	+0.2%	+$19.2K	3.84%	3
2022 Q2	$11.6M	Sell	1,089,755 -22,224	-2%	-$188K	3.99%	2
2022 Q1	$10.8M	Sell	1,111,979 -80,400	-7%	-$761K	3.24%	3
2021 Q4	$17.1M	Sell	1,192,379 -31,050	-3%	-$471K	4.35%	2
2021 Q3	$24.5M	Buy	1,223,429 +16,450	+1%	+$291K	5.93%	1
2021 Q2	$26.6M	Buy	+1,206,979	New	+$33.3M	5.99%	1